
False
Advertisement

About David Pyott
David Pyott
David Pyott is credited with turning Allergan from a small eyecare business to a leading global specialty pharmaceutical and medical device company. This progress was driven by Pyott principally through significant investment in research and development, increasing the company’s investment from under $100 million in 1998 to more than $1 billion in 2013.
Explore More in Ophthalmology
Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
Newsletters
Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

False
Advertisement
False
Advertisement
False
Advertisement
Disclaimer
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: